Related Experiment Video

Updated: Jul 21, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Aberrant methylation of cyclooxygenase-2 in breast cancer patients

L W C Chow1, L Zhu, W T Y Loo

  • 1Hung Chao Hong Integrated Center for Breast Diseases, Department of Surgery, The University of Hong Kong Medical Center, China. lwcchow@hkucc.hku.hk

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|March 2, 2006
PubMed
Abstract

Insights

Aberrant methylation of the cyclooxygenase-2 (COX-2) promoter was observed in 18.2% of breast cancers. COX-2 promoter methylation correlates with favorable prognostic factors, suggesting a role in breast cancer regulation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Aberrant CpG island methylation and gene silencing are implicated in various cancers.
  • The role of cyclooxygenase-2 (COX-2) promoter methylation in breast cancer remains largely unexplored.
  • This study investigates COX-2 methylation in breast tumors and its clinical associations.

Purpose of the Study:

  • To determine the methylation status of the COX-2 promoter in breast cancer.
  • To assess the correlation between COX-2 methylation and clinical characteristics in breast cancer patients.

Main Methods:

  • Analysis of COX-2 promoter methylation using bisulfite modification and methylation-specific PCR in 110 primary breast tumors.
  • Evaluation of COX-2 protein expression via immunohistochemistry (IHC).

Main Results:

  • Aberrant COX-2 promoter methylation detected in 18.2% (20/110) of breast cancers.
  • Loss of COX-2 protein expression observed in all methylated tumors.
  • COX-2 methylation significantly correlated with larger tumor size, lymph node metastasis, and lymphovascular permeation.

Conclusions:

  • COX-2 promoter methylation is linked to favorable prognostic factors in breast cancer.
  • Epigenetic silencing of COX-2 via promoter methylation is a potential mechanism for regulating its expression in breast tumors.

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...